Mrv1718006241812242D 19 20 0 0 0 0 999 V2000 -0.7722 -0.3023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.1847 0.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4396 0.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3597 0.9671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1047 0.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0856 -1.1273 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 -1.7367 1.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2466 0.0110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.5437 1.4087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7722 -1.1273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7987 0.6240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3711 -1.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6566 -1.1273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4818 2.3649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0577 -1.5398 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.0577 -2.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7987 -1.5332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0830 -0.3006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3017 -1.9208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 0 0 0 0 5 1 1 0 0 0 0 10 1 1 0 0 0 0 3 2 2 0 0 0 0 7 2 1 0 0 0 0 4 2 1 0 0 0 0 8 3 1 0 0 0 0 5 4 2 0 0 0 0 12 6 1 0 0 0 0 14 7 1 0 0 0 0 9 7 2 0 0 0 0 11 8 2 0 0 0 0 11 9 1 0 0 0 0 15 10 1 0 0 0 0 13 12 1 0 0 0 0 15 13 1 0 0 0 0 15 16 1 6 0 0 0 6 17 1 0 0 0 0 6 18 2 0 0 0 0 6 19 1 0 0 0 0 M END > DB14126 > drugbank > C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O > InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1 > SGOIRFVFHAKUTI-ZCFIWIBFSA-N > C9H14N5O4P > 287.2123 > 287.078340473 > 8 > 33 > 25.540197161187024 > 1 > 3 > 0 > 0 > ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid > -1.51 > -3.4393994481442403 > -2.19 > 0 > 2 > -1 > 7.905167029353834 > 1.3503658045649996 > 3.7449691065560664 > 136.38 > 67.535 > 5 > 1 > 1.87e+00 g/l > tenofovir > 0 > DB14126 > experimental; investigational > Tenofovir > (R)-PMPA; Anhydrous tenofovir; Tenofovir; Tenofovir (anh.); Tenofovir (anhydrous); Tenofovir anhydrous > Tenofovir hydrate $$$$